Synapse Medicine news and updates

Every material change AI Health Index has tracked at Synapse Medicine: new modules, model and architecture updates, clinical evidence, regulatory status, security certifications, and integration depth. Each entry states what changed, cites its source, and carries our read on what it means for a buyer. The graded assessment of this vendor across all fifteen capability axes sits on its index profile.

Funding rounds, valuations, and awards are not product changes and are not logged here. Acquisitions appear only where there is direct product impact.

Follow this change log by RSS

Free for your reader, newsletter or automation tool. One feed covers the whole index, and every category has its own.

All feeds and terms
Impact
Type
1 entry
Showing changes for Synapse Medicine only.Show the full log

November 2026

S
Synapse Medicine
Nov 5, 2026
HighVerified
Product / capability

Synapse Medicine opened its MedGPT medical AI assistant to healthcare professionals in Germany, Italy, Spain, Portugal, Belgium, the Netherlands, Poland, the UK, Ireland and Switzerland via medgpt.eu, after a beta limited to testers since July. MedGPT is now available in eight languages (French, English, German, Spanish, Italian, Portuguese, Dutch, Polish), answers in the user's language, and applies the guidelines of the country of practice declared at sign up.

Our read

Clinicians and hospital groups outside France can now use MedGPT with country specific guidance in their own language. The vendor states data is hosted in France on HDS certified infrastructure and is not used to train the AI models, which bears on PHI stewardship reviews.

Related axis: Setting and Specialty CoverageVendor announcementView source

What has changed at Synapse Medicine recently?

The most recent change AI Health Index logged at Synapse Medicine is dated Nov 5, 2026. Synapse Medicine opened its MedGPT medical AI assistant to healthcare professionals in Germany, Italy, Spain, Portugal, Belgium, the Netherlands, Poland, the UK, Ireland and Switzerland via medgpt.eu, after a beta limited to testers since July.